Atlas Trials

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma

Clinical trial NCT00003472 · TERMINATED

Trial details

NCT number
NCT00003472
Sponsor
Burzynski Research Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Oligodendroglioma, Adult
Start date
1996-05-01
Primary completion
2007-09-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.